BPC 157 (Body Protection Compound 157) Peptide for Tissue Repair & R ELITE BIO COMPOUNDS The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters MedShadow Foundation FDA's Overreach on Compounded Peptides Blog Best Way to Take BPC 157: Dosage & Administration